Search Results

Linker-Free Hyaluronic Acid-Dexamethasone Conjugates: pH-Responsive Nanocarriers for Targeted Anti-Inflammatory Therapy.

• Authors : Bokatyi, Anton N.¹ (AUTHOR); Dubashynskaya, Natallia V.^1,2 (AUTHOR); Kudryavtsev, Igor V.^1,2 (AUTHOR)

• Source: International Journal of Molecular Sciences. Jul2025, Vol. 26 Issue 14, p6608. 19p.

Record details

Cellulose-Based Scaffolds with Prolonged Dexamethasone Release for Bone Tissue Engineering.

• Authors : Liesienė, Jolanta¹ (AUTHOR) ; Baniukaitiene, Odeta^1,2 (AUTHOR); Minseviciene, Ieva^1,2 (AUTHOR)

Subjects: *Cellulose; *Dexamethasone; *Tissue scaffolds

• Source: Molecules. Jul2025, Vol. 30 Issue 13, p2760. 13p.

Record details

Isolated nodular hepatic tuberculosis in an immunocompetent patient following dexamethasone treatment for COVID-19.

• Authors : Seong, Jichang¹ (AUTHOR); Dilshod, Egamberdiev² (AUTHOR); Ravshan, Abdusattorov^1,3 (AUTHOR)

• Source: Oxford Medical Case Reports. May2025, Vol. 2025 Issue 5, p1-4. 4p.

Record details

The Efficacy of Oral Dexamethasone in the Management of Symptomatic Irreversible Pulpitis Without Pulpotomy: A Non-Randomized Clinical Trial.

• Authors : Chehab, Sara¹ (AUTHOR); Abiad, Roula² (AUTHOR); Nasr, Lara³ (AUTHOR)

• Source: Surgeries (2673-4095). Mar2025, Vol. 6 Issue 1, p22. 12p.

Record details

Streptococcus salivarius subsp. thermophilus ST-G30 Prevents Dexamethasone-Induced Muscle Atrophy in C2C12 Myotubes.

• Authors : Li, Mengjie^1,2,3; Kang, Seong-Gook^2,4; Huang, Kunlun^1,2,3

Subjects: *Streptococcus salivarius; *Biological models; *In vitro studies

• Source: Nutrients. Apr2025, Vol. 17 Issue 7, p1141. 17p.

Record details

Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) (EXCALIBER-RRMM)

• Source: A Phase 3, Two-Stage, Randomized, Multicenter, Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and

Record details

Romiplostim Plus Dexamethasone vs Dexamethasone in Patients With Newly Diagnosed Primary Immune Thrombocytopenia (RODEX)

• Source: A Multicentre, Randomized, Open-label Study of Romiplostim Plus Dexamethasone vs Dexamethasone in Patients With Newly Diagnosed Primary

Record details

Testing the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexamethasone or Daratumumab, Carfilzomib, Dexamethasone) for Patients With High-risk Multiple Myeloma Refractory or in First Relapse

• Source: A Randomized Phase II Trial for High-Risk Multiple Myeloma That is Refractory or in First Relapse With Daratumumab, Teclistamab (DT) Versus Daratumumab, Pomalidomide,

Record details

Conventional Prophylactic Oral Dexamethasone vs Short-course IV Dexamethasone in Paclitaxel Hypersensitivity

• Authors : Linda Hong, MD, Primary Investigator

• Source: Conventional Prophylactic Regimen of Oral Dexamethasone Versus Short-course Intravenous Dexamethasone in Preventing Paclitaxel-related

Record details

Testing the Investigational Agent Combination of Daratumumab, Bortezomib, and Dexamethasone Compared to the Usual Treatment of Cyclophosphamide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients With Kidney Failure

• Authors : National Cancer Institute (NCI)

• Source: A Randomized Phase II Trial Comparing Daratumumab-Bortezomib-Dexamethasone Versus Cyclophosphamide-Bortezomib-Dexamethasone in Newly

Record details